Nabumetone
- Product NDC
- 45865-111
- 11-digit product format
- 458650111
- Labeler code
- 45865
- Product ID
- 45865-111_b523dbfe-898f-c75b-e053-2a95a90a7ea2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nabumetone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Medsource Pharmaceuticals
- Application
- ANDA078420
- Marketing category
- ANDA
- Marketing start
- 2020-07-01
- Marketing end
- 0000-00-00
- Substance
- NABUMETONE
- Active strength
- 750 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 45865-111-60 | Nabumetone | 60 in 1 BOTTLE | TABLET | 60 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 45865-111 | NABUMETONE TABLET [MEDSOURCE PHARMACEUTICALS] | 1 | Legacy NDC, 1 package rows | 20201128_b523da6c-bd32-7f41-e053-2995a90afc6a.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 45865-111-60 | 45865011160 | 60 TABLET in 1 BOTTLE (45865-111-60) | 60 tablet | 2020-07-01 | 0000-00-00 | No | No | Current |